Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Shelburne

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|June 30, 2011
The mast cell in innate and adaptive immunityChristopher P Shelburne, Soman N Abraham
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2005
In vivo models for studying mast cell-dependent responses to bacterial infectionChristopher P Shelburne, James B McLachlan, Soman N Abraham
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosisJeoung-Sook Shin, Christopher P Shelburne, Cong Jin, et al.
Cytokine|October 24, 2002
Mast cell-restricted p70 Stat6 isoform is a product of selective proteolysisChristopher P Shelburne, Roland P Piekorz, L Andrew Bouton, et al.
Vaccine|May 26, 2009
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigenAfton L McGowen, Laura P Hale, Christopher P Shelburne, et al.
Nature Immunology|November 5, 2003
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infectionJames B McLachlan, Justin P Hart, Salvatore V Pizzo, et al.
The Journal of Clinical Investigation|February 3, 2011
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activationCong Jin, Christopher P Shelburne, Guojie Li, et al.
Nature Medicine|April 22, 2008
Mast cell activators: a new class of highly effective vaccine adjuvantsJames B McLachlan, Christopher P Shelburne, Justin P Hart, et al.
Cell Host & Microbe|October 20, 2009
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissuesChristopher P Shelburne, Hideki Nakano, Ashley L St John, et al.
Medchemcomm|May 14, 2013
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating AgentsHerman F Staats, Shaun M Kirwan, Hae Woong Choi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|June 30, 2011
The mast cell in innate and adaptive immunityChristopher P Shelburne, Soman N Abraham
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2005
In vivo models for studying mast cell-dependent responses to bacterial infectionChristopher P Shelburne, James B McLachlan, Soman N Abraham
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosisJeoung-Sook Shin, Christopher P Shelburne, Cong Jin, et al.
Cytokine|October 24, 2002
Mast cell-restricted p70 Stat6 isoform is a product of selective proteolysisChristopher P Shelburne, Roland P Piekorz, L Andrew Bouton, et al.
Vaccine|May 26, 2009
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigenAfton L McGowen, Laura P Hale, Christopher P Shelburne, et al.
Nature Immunology|November 5, 2003
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infectionJames B McLachlan, Justin P Hart, Salvatore V Pizzo, et al.
The Journal of Clinical Investigation|February 3, 2011
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activationCong Jin, Christopher P Shelburne, Guojie Li, et al.
Nature Medicine|April 22, 2008
Mast cell activators: a new class of highly effective vaccine adjuvantsJames B McLachlan, Christopher P Shelburne, Justin P Hart, et al.
Cell Host & Microbe|October 20, 2009
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissuesChristopher P Shelburne, Hideki Nakano, Ashley L St John, et al.
Medchemcomm|May 14, 2013
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating AgentsHerman F Staats, Shaun M Kirwan, Hae Woong Choi, et al.
Pageof 2